U.S. market Open. Closes in 3 hours 31 minutes

RANI | Rani Therapeutics Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.9600 - 2.0350
52 Week Range 1.9020 - 8.75
Beta -0.26
Implied Volatility 246.90%
IV Rank 59.18%
Day's Volume 171,450
Average Volume 1,763,761
Shares Outstanding 57,427,542
Market Cap 113,132,258
Sector Healthcare
Industry Biotechnology
IPO Date 2021-07-30
Valuation
Profitability
Growth
Health
P/E Ratio -1.88
Forward P/E Ratio N/A
EPS -1.05
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 140
Country USA
Website RANI
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
*Chart delayed
Analyzing fundamentals for RANI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see RANI Fundamentals page.

Watching at RANI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on RANI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙